当前位置: 首页 > 期刊 > 《中国医学创新》 > 2021年第26期
编号:185547
血清对称二甲基精氨酸水平对肾囊腺瘤的诊断及预后价值分析
http://www.100md.com 2021年3月27日 中国医学创新 2021年第26期
     许鑫

    【关键词】 SDMA 肾囊腺瘤 诊断 预后

    [Abstract] Objective: To explore the diagnostic and prognostic value of serum symmetrical dimethylarginine (SDMA) level in renal cystic adenoma. Method: A total of 60 patients with renal cystic adenoma treated in our hospital from January 2017 to January 2020 were selected as the study group, 50 patients with benign renal lesions treated in our hospital in the same period were selected as the control group. The levels of SDMA, alpha fetoprotein (AFP) and carcinoembryonic antigen (CEA) in the two groups were detected. The patients in the study group were divided into stage Ⅰ, Ⅱ (n=37) and stage Ⅲ, Ⅳ (n=23) according to TNM stage; according to the clinical outcome of 6-month follow-up ......

您现在查看是摘要页,全文长 11237 字符